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Purpose: The prognostic significance of perineural invasion by prostate cancer is debated. 
We investigated the association between perineural invasion and clinicopathological 
factors and the effect of perineural invasion on survival in patients with prostate cancer.
Materials and Methods: A total of 361 patients with prostate cancer without any neo-
adjuvant therapies prior to surgery from 1999 to 2010 were analyzed retrospectively. 
Whole-mount sections of surgical specimens from all patients who underwent radical 
prostatectomy were evaluated. Positive perineural invasion was defined as infiltration 
of cancer cells in the perineurium or neural fascicles. The relationship of perineural 
invasion with clinicopathological features and prognosis of prostate cancer was studied. 
We also researched preoperative factors that were associated with perineural invasion.
Results: Perineural invasion in a prostatectomy specimen (PNIp) was positive in 188 
of 361 patients (52.1%). In the multivariate analysis of the preoperative variables, PNIp 
was related to the primary Gleason grade (p=0.020), the number of positive cores (p= 
0.008), and the percentage of tumor cells in positive cores (p=0.021), but not to perineural 
invasion of a prostate biopsy. In the evaluation between PNIp and pathologic findings 
of the prostatectomy specimen, PNIp was related to the Gleason score (p=0.010), 
T-stage (p=0.015), and lymphovascular invasion (p=0.019). However, by multivariate 
analysis, the PNIp was not an independent prognostic factor of biochemical serum re-
currence (p=0.364) or cancer-specific survival (p=0.726).
Conclusions: PNIp was significantly related to biologically aggressive tumor patterns 
but was not a prognostic factor for biochemical serum PSA recurrence or cancer-specific 
survival in patients with prostate cancer.
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INTRODUCTION
A distinctive feature of cancer cells is their ability to dis-
sociate from the primary tumor and establish metastases 
at various sites. The common routes by which cancer cells 
spread include local invasion, and lymphatic, hemato-
genous, and peritoneal dissemination. The hematogenous 
and lymphatic pathways are well-established routes of 
metastatic spread. However, although routes along nerves 
have been described in the literature since the mid-1800s, 
they have received relatively little research attention [1]. 
Recently, it has become increasingly evident that cancer- 
stromal interactions play a critical role in cancer growth 
and progression. The involvement of peripheral nerves has 
been overlooked for a long time; these nerves have been con-
sidered inert bystanders in solid malignancies, but they are 
now gaining recognition as potentially important compo-
nents of the cancer microenvironment. Cancer cells invade 
both the epineurium and the perineurium, and may reach 
the endoneurium, becoming intimately associated with Korean J Urol 2010;51:745-751
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TABLE 1. Preoperative and postoperative patient characteristics
Preoperative (prostate biopsy) characteristics
　Age (yr) 69.0±6.8 (49-94)
　PSA (ng/ml) 15.6±18.6
　Primary Gleason grade
　　3 (%) 235 (65.1)
　　4 (%) 113 (31.3)
　　5 (%) 13 (3.6)
　Secondary Gleason grade
　　3 (%) 236 (65.4)
　　4 (%) 115 (31.9)
　　5 (%) 10 (2.8)
　Gleason score
　　≤6 (%) 191 (52.9)
　　7 (%) 121 (33.5)
　　≥8 (%) 49 (13.6)
　Occurrence of a high Gleason grade (＞3) 170 (47.1)
　No. of positive cores 3.2±2.1
　Percentage of positive biopsy cores (%) 38.4±24.9
　Percentage of tumor cells
　    in the positive cores (%)
49.3±27.2
　Bilaterality (%) 111 (30.7)
　Perineural invasion (%) 14 (7.4)
Postoperative characteristics
　Primary Gleason grade
　　3 (%) 235 (65.1)
　　4 (%) 114 (31.6)
　　5 (%) 12 (3.3)
　Secondary Gleason grade
　　3 (%) 199 (55.1)
　　4 (%) 143 (39.6)
　　5 (%) 19 (5.3)
　Gleason score
　　≤6 (%) 144 (39.9)
　　7 (%) 170 (47.1)
　　≥8 (%) 47 (13.0)
　T stage
　　2a (%) 46 (12.8)
　　2b (%) 55 (15.3)
　　2c (%) 152 (42.1)
　　3a (%) 68 (18.8)
　　3b (%) 37 (10.2)
　　4 (%) 3 (0.8)
　Tumor volume (%) 22.5±22.9
　Lymphovascular invasion (%) 40 (11.1)
　Perineural invasion (%) 188 (52.1)
　Surgical margin positive (%) 146 (40.4)
　Pelvic lymph node metastasis (%) 13 (3.6)
　Nadir PSA (ng/ml)
　　＜0.2 (%) 330 (91.4)
　　≥0.2 (%) 31 (8.6)
　Biochemical recurrence (%) 83 (23.0)
　Death (%) 65 (18.0)
PSA: prostate-specific antigen
Schwann cells and nerve axons [1]. Perineural invasion 
was first reported in the English literature by doctors who 
described head and neck cancers with a predilection for 
growth along nerves, as they made their way toward the 
intracranial fossa [2].
　The clinical significance of perineural invasion is contro-
versial. D’Amico et al showed that perineural invasion is 
an independent prognostic factor for prostate cancer re-
currence [3]. However, Freedland et al reported that peri-
neural invasion did not correlate with extracapsular ex-
tension or biochemical recurrence [4].
　We compared the preoperative prediction of perineural 
invasion in a prostate biopsy (PNIb) with that of perineural 
invasion in a prostatectomy specimen (PNIp) and inves-
tigated the clinical and prognostic significance of PNIp in 
prostate cancer patients.
MATERIALS AND METHODS
1. Patients and preoperative parameters
We reviewed the medical records of 361 consecutive patients 
with prostate adenocarcinomas who had received no hor-
monal therapy or radiation therapy before or after a retro-
pubic radical prostatectomy or laparoscopic radical prosta-
tectomy, performed between 1999 and 2010. Data pertain-
ing to the demographics, staging, pathology, and outcomes 
of each patient were reviewed and entered into a compre-
hensive database. All procedures involving study partic-
ipants were approved by the Institutional Review Board 
(IRB approved protocol number: E2010-014). The period of 
observation of this unselected cohort was the interval be-
tween the date of the surgical resection and the last contact 
(death or last follow-up). The mean duration of follow-up 
was 42.4±33.6 months (range, 6.5-141.6 months).
　The patient characteristics and pathological parameters 
are listed in Table 1. The mean patient age at the time of 
radical prostatectomy was 69.0 years (range, 49-94 years). 
Prostate biopsies were recommended for men with a serum 
prostate-specific antigen (PSA) level of 3.0 ng/ml or higher. 
We evaluated the primary Gleason grade, secondary Gleason 
grade, Gleason score, occurrence of a high Gleason grade 
(＞3), percentage of positive biopsy cores, percentage of tumor 
cells in the positive cores, bilaterality, and perineural in-
vasion in a prostate biopsy. The percentage of positive biop-
sy cores was defined as: (number of positive biopsy cores/to-
tal number of biopsy cores) x100. We analyzed the associa-
tion between the preoperative parameters cited above and 
PNIp to evaluate the preoperative prediction of PNIp.
2. Assessment of clinicopathologic factors
Either a medical or a surgical oncologist who was a member 
of our institution’s multidisciplinary tumor board at the 
time of the patient’s treatment established the tumor stage 
postoperatively, according to the tumor, lymph node, meta-
stasis (TNM) classification of the International Union 
Against Cancer (UICC 2002) and the Gleason system [5]. 
We reviewed the primary Gleason grade, secondary Gleason 
grade, Gleason score, presence of a high Gleason grade (＞
3), presence of Gleason grade 5, T-stage, tumor volume, 
lymphovascular invasion, surgical margin status, peri-Korean J Urol 2010;51:745-751
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FIG. 1. Perineural invasion of prostate cancer cells. Prostate 
cancer cells grow along the nerve branch (red arrow) (H&E, x400).
neural invasion, pelvic lymph-node metastasis at radical 
prostatectomy, and nadir PSA. Tumor volume was defined 
as the volume of cancer cells relative to the total resected 
prostate volume. Perineural invasion was defined as tumor 
cells within any layer of the nerve sheath or tumor cells in 
the perineural space that involved at least one third of the 
nerve circumference. Lymphovascular invasion was de-
fined as the presence of cancer cells within an endothe-
lium-lined space without a muscular wall.
　Nadir serum PSA was checked 4-6 weeks after the radical 
prostatectomy. We also followed up the serum PSA every 
3 months during the first year after surgery, semiannually 
in years 2 to 5, and annually thereafter. The cutoff value 
for biochemical serum PSA recurrence was defined as 0.2 
ng/ml.
　Survival records were obtained from the Korean National 
Statistics Registry Database, and the cancer-specific sur-
vival data were analyzed.
3. Histopathological analysis
All radical prostatectomy specimens were evaluated in a 
standard manner. After eliminating the apical and bladder 
neck margins, the specimens were sectioned transversely 
at 5 mm intervals from the apex to the base. The seminal 
vesicles were evaluated at the intersection at which they 
entered the prostate gland. Whole-mount sections (5 μm 
thick) were stained with H&E. The apical and bladder neck 
margins and the anterior, radial, posterior, and postero-
lateral surgical margins were defined as positive if the tu-
mor was in direct contact with the indicated inked surface 
of the prostate in the sections.
　The original H&E stained slides from the tumor re-
sections were collected from the pathology department. All 
slides containing tumor cells were reviewed for PNIp by a 
single pathologist with expertise in PNIp, who was blinded 
to all patient data, including the stage of the disease and 
its outcome.
4. Statistical analysis
The associations between the preoperative parameters 
and PNIp were calculated with a binary logistic regression 
model and the Mantel-Haenszel χ
2 test. The association of 
PNIp with various clinicopathological characteristics was 
assessed by using the (two-tailed) Pearson correlation test. 
The influence of PNIp on biochemical recurrence and over-
all and cancer-specific survival were estimated by using the 
Kaplan-Meier method with a log-rank test. The effects of 
PNIp and other clinicopathological parameters on bio-
chemical recurrence and cancer-specific survival were ana-
lyzed by using the Cox regression model. All analyses were 
performed with SPSS ver. 15.0 (SPSS Inc., Chicago, IL, 
USA). All results were considered significant at p＜0.05.
RESULTS
1. Incidence of perineural invasion in prostate cancer
Fifty-two percent of patients (188 of 361 patients) had a pos-
itive PNIp (Fig. 1). Only 7.4% of these patients (14 of 188 
patients) were identified as having positive PNIb, demon-
strating the underreporting of this pathology in prostate 
biopsies.
2. Preoperative prediction of PNIp (Table 2)
In evaluating the relations between the preoperative varia-
bles and PNIp, PNIp was related to preoperative PSA (p= 
0.002), the primary Gleason grade (p＜0.001), secondary 
Gleason grade (p=0.003), Gleason score (p＜0.001), a Glea-
son grade ＞3 (p＜0.001), the number of positive cores (p＜ 
0.001), the percentage of positive cores (p＜0.001), and the 
percentage of tumor cells in positive-core prostate biopsies 
(p＜0.001), but not to age (p=0.069), bilaterality (p=0.175), 
or perineural invasion at prostate biopsy (p=0.277). In a 
multivariate analysis, PNIp was related to the primary 
Gleason grade (p=0.020, hazard ratio=2.040, 95% confi-
dence interval [CI] 1.119-3.719), the number of positive 
cores (p=0.008, hazard ratio=1.303, 95% CI: 1.072-1.582), 
and the percentage of tumor cells in positive cores (p=0.021, 
hazard ratio=1.015, 95% CI: 1.002-1.029) at prostate biopsy.
3. Relation between PNIp and known prognostic factors in 
prostatectomy specimens (Table 3)
In a univariate analysis, PNIp was correlated with the pa-
thological stage of the prostatectomy specimen (p＜0.001). 
Perineural invasion was observed in 50% of T2a tumors, 
11.1% of T2b tumors, 48.3% of T2c tumors, 79.4% of T3a 
tumors, 91.9% of T3b tumors, and 100% of T4 tumors. The 
Gleason score and the primary and secondary Gleason 
grades were also significantly related to PNIp (p＜0.001, 
p=0.019, and p＜0.001, respectively). PNIp was observed 
in 39.3% of patients with a Gleason grade of ≤3 and in 71.5% 
of patients with a Gleason grade of ＞3. PNIp was observed 
in 81.3% of patients with a Gleason grade of 5.
　The tumor volume of the prostate cancer was higher in 
the PNIp-positive specimens than in the PNIp-negative Korean J Urol 2010;51:745-751
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TABLE 3. Relationship between PNIp and prognostic factors on prostatectomy specimens
Parameters
Univariate analysis Multivariate analysis
p-value p-value HR 95% CI
Primary Gleason grade 0.019 0.075 0.529 0.263-1.065
Secondary Gleason grade ＜0.001 0.989 1.243 0.342-3.254
Gleason score ＜0.001 0.010 1.959 1.178-3.256
T stage ＜0.001 0.015 1.387 1.065-1.807
Tumor volume ＜0.001 0.061 1.016 0.999-1.033
Lymphovascular invasion ＜0.001 0.019 3.863 1.247-11.967
Surgical margin status 0.002 0.626 1.152 0.651-2.040
No. of positive lymph nodes 0.204
Nadir PSA 0.164
PNIp: perineural invasion in a prostatectomy specimen, HR: hazard ratio, CI: confidence interval, PSA: prostate-specific antigen
TABLE 2. Univariate and multivariate analysis between preoperative parameters and PNIp
Parameters
Univariate analysis Multivariate analysis
p-value p-value HR 95% CI
Age 0.069
Preoperative PSA 0.002 0.153 1.016 0.994-1.039
Primary Gleason grade ＜0.001 0.020 2.040 1.119-3.719
Secondary Gleason grade 0.003 0.820 0.904 0.382-2.143
Gleason score ＜0.001 0.798 1.121 0.592-1.467
Gleason grade ＞3 ＜0.001 0.895 1.057 0.464-2.408
No. of positive cores ＜0.001 0.008 1.303 1.072-1.582
Percentage of positive cores ＜0.001 0.653 1.008 0.975-1.041
Percentage of tumor cells in positive core ＜0.001 0.021 1.015 1.002-1.029
Bilaterality 0.175
PNIb 0.277
PNIp: perineural invasion in a prostatectomy specimen, HR: hazard ratio, CI: confidence interval, PSA: prostate-specific antigen, PNIb:
perineural invasion in the prostate biopsy
specimens (27.7% vs 14.5%, respectively; p＜0.001). PNIp 
was observed almost twice as frequently in surgical-margin- 
positive specimens at the time of radical prostatectomy 
than in the surgical-margin-negative specimens (53.5% vs 
35.7%, respectively; odds ratio 2.069, p=0.003). PNIp showed 
a slight correlation with lymph-node metastasis (5.3% vs 
0.8%, respectively; odds ratio: 7.022, p=0.055). In a multi-
variate analysis, PNIp was significantly related to the 
Gleason score (p=0.010, hazard ratio=1.959, 95% CI: 1.178- 
3.256), T-stage (p=0.015, hazard ratio=1.387, 95% CI: 1.065- 
1.807), and lymphovascular invasion (p=0.019, hazard ra-
tio=3.863, 95% CI: 1.247-11.967).
4. Role of PNIp in biochemical recurrence of prostate cancer 
(Table 4)
The relations between PNIp and other clinical and patho-
logical parameters were investigated with the Pearson 
correlation. Age (p=0.022), primary Gleason grade (p＜ 
0.001), Gleason score (p＜0.001), tumor stage (p＜0.001), 
tumor volume of the prostate (p＜0.001), lymphovascular 
invasion (p＜0.001), PNIp (p=0.018), surgical margin sta-
tus (p=0.018), number of positive lymph nodes (p=0.004), 
nadir PSA (p＜0.001), the first PSA after surgery (p= 
0.041), PSA at 1 year after surgery (p＜0.001), and PSA ve-
locity (p=0.049) were significantly related to biochemical 
serum PSA recurrence. Using the log-rank test, we found 
no significant difference in biochemical serum PSA re-
currence between patients with PNIp and those without 
PNIp (p=0.597; Fig. 2). In a multivariate analysis, nadir 
PSA (p＜0.001, hazard ratio=61.746, 95% CI: 15.363- 
248.174) and PSA at 1 year after surgery (p＜0.001, hazard 
ratio=2.878, 95% CI: 1.893-4.375) were significantly related 
to biochemical serum PSA recurrence. However, PNIp was 
not correlated with biochemical recurrence (p=0.364).
5. PNIp is not an independent prognostic factor for outcome 
in prostate cancer (Table 5)
In a Kaplan-Meier survival analysis, the Gleason score, 
preoperative PSA, and nadir PSA were significantly re-
lated to cancer-specific survival (p＜0.001, p＜0.001, and 
p＜0.001, respectively). However, PNIp did not correlate 
with cancer-specific survival (p=0.726; Fig. 3).
　A Cox proportional multivariate analysis was used to as-
sess the influence of all the significant parameters on can-Korean J Urol 2010;51:745-751
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TABLE 4. Relationship between parameters and biochemical recurrence
Parameters
Univariate analysis Multivariate analysis
p-value p-value HR 95% CI
Age 0.022 0.622 0.985 0.928-1.045
Primary Gleason grade ＜0.001 0.120 1.599 0.885-2.890
Secondary Gleason grade 0.073
Gleason score ＜0.001 0.290 0.733 0.411-1.304
T stage ＜0.001 0.309 1.134 0.890-1.445
Tumor volume ＜0.001 0.596 0.996 0.981-1.011
Lymphovascular invasion ＜0.001 0.860 1.086 0.434-2.716
PNIp 0.018 0.364 0.718 0.352-1.468
Surgical margin status 0.018 0.344 1.396 0.700-2.784
No. of positive lymph nodes 0.004 0.022 2.256 1.123-4.532
Nadir PSA ＜0.001 ＜0.001 61.746 15.363-248.174
The first PSA after surgery 0.041 0.587 0.989 0.952-1.028
PSA at 1 year after surgery ＜0.001 ＜0.001 2.878 1.893-4.375
PSA velocity 0.049 0.329 1.010 0.990-1.030
HR: hazard ratio, CI: confidence interval, PNIp: perineural invasion in a prostatectomy specimen, PSA: prostate-specific antigen
FIG. 2. Cumulative biochemical recurrence rate according to 
perineural invasion in a prostatectomy specimen (PNIp). The 
5-year biochemical recurrence rate with and without PNIp was 
0.808 and 0.850, respectively.
FIG. 3. Cumulative survival rate according to perineural invasion
in a prostatectomy specimen (PNIp). The 5-year survival rate with
and without PNIp was 0.914 and 0.777, respectively.
TABLE 5. Relationship between parameters and cancer-specific survival
Parameters
Univariate analysis Multivariate analysis
p-value p-value HR 95% CI
Primary Gleason grade 0.534
Secondary Gleason grade 0.748
Gleason score ＜0.001 0.047 1.412 1.005-1.986
T stage 0.456
Tumor volume 0.735
Lymphovascular invasion 0.533
Surgical margin status 0.984
PNIp 0.726
Nadir PSA ＜0.001 0.940 0.973 0.479-1.979
Preoperative PSA ＜0.001 0.673 1.004 0.987-1.021
HR: hazard ratio, CI: confidence interval, PNIp: perineural invasion in a prostatectomy specimen, PSA: prostate-specific antigenKorean J Urol 2010;51:745-751
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cer-specific survival and 5-year PSA-recurrence-free sur-
vival. The Gleason score was significantly associated with 
a poor prognosis (p=0.047, hazard ratio=1.412, 95% CI: 
1.005-1.986). The presence of PNIp did not correlate with 
biochemical recurrence or cancer-specific survival.
DISCUSSION
Perineural invasion has become an increasingly relevant, 
yet understudied, aspect of tumor biology in several can-
cers, including prostate cancer. The role of perineural in-
vasion and its utility to clinicians continue to be debated 
[6]. Because the incidence of prostate cancer is increasing 
rapidly in Korea [7], we sought to determine the impact of 
perineural invasion on prostate cancer in our patient po-
pulation.
　Previous studies have reported incidences of PNIb of 
7-43% and of PNIp of 31.9-79.0% [3,8-12]. In the present 
study, PNIb and PNIp were observed in 7.4% and 52.8% of 
patients, respectively, which means that PNIb has only 
limited prognostic value and more attention should be di-
rected to pathological examinations. However, PNIp was 
related to the primary Gleason grade, secondary Gleason 
grade, Gleason score, Gleason grade of ＞3, the number of 
positive cores, the percentage of positive cores, and the per-
centage of tumor cells in the positive cores on prostate 
biopsies. This result indicates that biopsy specimens do not 
represent the whole prostate pathology, even when multi-
ple prostate biopsies are performed.
　The clinical significance of PNIb is controversial. Some 
reports have shown that PNIb does not predict biochemical 
PSA recurrence after radical prostatectomy [4,9]. However, 
other reports have demonstrated that PNIb is significantly 
related to postoperative biochemical recurrence [8,13]. 
Loeb et al showed that PNIb is an independent risk factor 
for aggressive pathological features and a nonindependent 
risk factor for biochemical progression after radical prosta-
tectomy [8]. A limitation of our study was that we could not 
assess the exact predictive value of PNIb for biochemical 
recurrence because the number of patients with positive 
PNIb was small.
　Lee et al showed a statistically significant association be-
tween the presence of PNIp and adverse preoperative risk 
parameters, including a higher clinical T-stage, higher 
Gleason score at biopsy, and higher preoperative serum 
PSA [14]. Another report also demonstrated that PNIp was 
significantly related to preoperative serum PSA and PSA 
density [15]. In our study, we found that PNIp was sig-
nificantly related to the primary Gleason grade, the per-
centage of positive cores, and the percentage of positive 
cores on prostate biopsy.
　Recently, Jeon and colleagues also reported that PNIp 
was related to a higher Gleason score, extracapsular ex-
tension, seminal vesicle invasion, and a positive surgical 
margin [15]. Stone et al reported that PNIp predicted pelvic 
lymph node metastasis in men with prostate cancer [16]. 
In the present study, we also found that PNIp correlated 
with several clinicopathological parameters, including the 
pathological T-stage, Gleason score, and lymphovascular 
invasion.
　Stone et al showed that PNIp is an independent predictor 
of lymph node metastasis in prostate cancer patients [16]. 
Another report suggested PNIp as a marker for pathologi-
cally advanced prostate cancer [14]. However, Miyake et 
al reported that PNIp is not an independent predictor of bio-
chemical recurrence and might not provide any extra use-
ful information when the presence of perineural invasion 
is considered in predicting the prognosis of men under-
going radical prostatectomy if there are other conventional 
parameters available [17]. Merrilees et al also suggested 
that PNIp does not predict biochemical serum PSA re-
currence [18]. Our data indicate that PNIp did not correlate 
with biochemical serum PSA recurrence, although it was 
related to other known prognostic factors.
　There are a few reports of the significance of perineural 
invasion for the survival of patients with prostate cancer 
[1]. However, most of these reports have limitations, be-
cause the studies included patients who had undergone ra-
diation therapy, so they evaluated the presence of PNIb, 
but not PNIp. Therefore, we could not compare our results 
with previous reports, including biochemical serum PSA 
recurrence or the survival rate, in patients who had under-
gone radical prostatectomy. Moreover, most studies have 
defined biochemical recurrence as the only study endpoint, 
whereas we evaluated the prognostic value of PNIp for can-
cer-specific survival. In our study, PNIp was not signifi-
cantly related to cancer-specific survival. In this study, the 
relationship between PNIp and biochemical recurrence 
did not show statistical significance according to T stage 
and Gleason score.
　One of the limitations of our study was that the number 
of patients with positive PNIb was very small, so we were 
unable to estimate the value of PNIb as a prognostic factor. 
Another limitation was that detailed biopsy core data were 
not available for some patients. We recorded the presence 
or absence of PNIb in all cases, but did not quantify the ex-
tent or laterality of PNIb in some patients. Because the 
Gleason grading system has been changed, all the speci-
men slides were reviewed by a single pathologist. However, 
we had only the pathology reports for some patients who 
had undergone prostate biopsies at another hospital. Before 
2005, we performed sextant prostate biopsies, whereas af-
ter 2005, extended multisite biopsies were performed. The 
rates of PNIb in the sextant biopsies and extended biopsies 
were 6.25% (4/64) and 3.37% (10/297), respectively. There-
fore, we considered that the number of biopsy cores did not 
affect the detection of perineural invasion at prostate biopsy.
CONCLUSIONS
We found that PNIb had limited value in predicting PNIp. 
PNIp was significantly related to biologically aggressive 
tumor patterns but was not a prognostic factor for bio-
chemical serum PSA recurrence or cancer-specific survival Korean J Urol 2010;51:745-751
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in patients with prostate cancer. The prognostic value of 
PNIp lacks statistical significance for biochemical serum 
PSA recurrence and cancer-specific survival.
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